These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 16281376)

  • 1. [Blood serum of patients with secondary progressive multiple sclerosis changes neuron electric activity].
    Sergeeva SS; Zaprianova E; Sotnikov OS; Deleva D; Fil'chev A; Sultanov B; Krasnova TV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):30-4. PubMed ID: 16281376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum IgG and IgM ganglioside GM1 antibodies in patients with multiple sclerosis.
    Zaprianova E; Majtényi K; Deleva D; Mikova O; Filchev A; Sultanov B; Kolyovska V; Sultanov E; Christova L; Kmetska X; Georgiev D
    Ideggyogy Sz; 2004 Mar; 57(3-4):94-9. PubMed ID: 15133910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against gangliosides GM1 of patients with multiple sclerosis alter the response of neurons to synaptic activation.
    Sergeeva SS; Zaprianova E; Sotnikov OS; Deleva D; Filchev A; Sultanov B
    Dokl Biol Sci; 2004; 399():461-3. PubMed ID: 15717608
    [No Abstract]   [Full Text] [Related]  

  • 4. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis.
    Pestronk A; Adams RN; Cornblath D; Kuncl RW; Drachman DB; Clawson L
    Ann Neurol; 1989 Jan; 25(1):98-102. PubMed ID: 2913936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside.
    Pestronk A; Cornblath DR; Ilyas AA; Baba H; Quarles RH; Griffin JW; Alderson K; Adams RN
    Ann Neurol; 1988 Jul; 24(1):73-8. PubMed ID: 2843079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyclonal IgM anti-GM1 ganglioside antibody in patients with motor neuron disease and variants.
    Salazar-Grueso EF; Routbort MJ; Martin J; Dawson G; Roos RP
    Ann Neurol; 1990 May; 27(5):558-63. PubMed ID: 2113790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies.
    Pestronk A
    Muscle Nerve; 1991 Oct; 14(10):927-36. PubMed ID: 1658646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies to GM1 ganglioside in motor neuron disease--in comparison with demyelinating neuropathy].
    Irie S; Saito T; Ogino M; Ito H; Kowa H
    Rinsho Shinkeigaku; 1992 Oct; 32(10):1075-80. PubMed ID: 1297550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower motor neuron syndrome associated with IgG anti-GM1 antibodies revisited.
    Yuki N; Yanaka C; Sudo M; Funakoshi M; Ishida H; Mori M; Kanda F; Hirata K
    J Neuroimmunol; 2014 Jul; 272(1-2):62-6. PubMed ID: 24841627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the antibodies to gangliosides on the Retzius neuron electrical activity and the functional activity of sodium channels for incoming current in leech].
    Sergeeva SS; Zaprianova E; Sotnikov OS; Deleva D; Fil'chev A
    Ross Fiziol Zh Im I M Sechenova; 2003 Jan; 89(1):66-74. PubMed ID: 12669595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-GM1 gangliosides antibodies in multifocal motor neuropathies].
    Younes-Chennoufi AB; Baumann N
    Rev Neurol (Paris); 1996 May; 152(5):375-9. PubMed ID: 8881433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional restructuring of the ultrastructure of the giant neuron (Retzius') in the medicinal leech and the possible role of Ca++ ions in these processes].
    Mashanskiĭ VF; Bazanova IS; Kazanskiĭ VV; Merkulova OS
    Arkh Anat Gistol Embriol; 1982 Mar; 82(3):36-42. PubMed ID: 7092587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the impulse activity of Retzius' neuron in the leech during synaptic activation at different frequencies].
    Sergeeva SS
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1994; 44(6):1144-7. PubMed ID: 7879441
    [No Abstract]   [Full Text] [Related]  

  • 14. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies.
    Pestronk A; Chaudhry V; Feldman EL; Griffin JW; Cornblath DR; Denys EH; Glasberg M; Kuncl RW; Olney RK; Yee WC
    Ann Neurol; 1990 Mar; 27(3):316-26. PubMed ID: 2327739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of anti-GM1 IgM antibodies.
    Nobile-Orazio E; Carpo M; Scarlato G
    Acta Neurol (Napoli); 1991 Dec; 13(6):514-9. PubMed ID: 1805551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to GM1 and GD1b in patients with motor neuron disease without plasma cell dyscrasia.
    Shy ME; Evans VA; Lublin FD; Knobler RL; Heiman-Patterson T; Tahmoush AJ; Parry G; Schick P; DeRyk TG
    Ann Neurol; 1989 May; 25(5):511-3. PubMed ID: 2505666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis and neuropathies.
    Lamb NL; Patten BM
    Muscle Nerve; 1991 Oct; 14(10):1021-7. PubMed ID: 1944401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning of human anti-GM1 antibodies from motor neuropathy patients.
    Willison HJ; Paterson G; Kennedy PG; Veitch J
    Ann Neurol; 1994 Apr; 35(4):471-8. PubMed ID: 8154875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.